אללייזו ישראל - עברית - Ministry of Health

אללייזו

pfizer pharmaceuticals israel ltd - taliglucerase alfa - אבקה להכנת תמיסה לאינפוזיה - taliglucerase alfa 200 u/vial - taliglucerase alfa - taliglucerase alfa - elelyso (taliglucerase alfa ) for injection is a hydrolytic lysosomal glucocerebroside - specific enzyme indicated for long - term enzyme replacement therapy (ert) for adults with a confirmed diagnosis of type 1 gaucher disease.

טרנדייט טבליות 100 מג ישראל - עברית - Ministry of Health

טרנדייט טבליות 100 מג

padagis israel agencies ltd, israel - labetalol hydrochloride - טבליה - labetalol hydrochloride 100 mg - labetalol - labetalol - treatment of all grades of hypertension (mild, moderate and severe) when oral antihypertensive therapy is desirable.

ליפופונדין אם.סי.טיאל.סי.טי % 10 ישראל - עברית - Ministry of Health

ליפופונדין אם.סי.טיאל.סי.טי % 10

lapidot medical import and marketing ltd - soya oil; triglycerides, medium-chain - תחליב לאינפוזיה - triglycerides, medium-chain 50 mg/ml; soya oil 50 mg/ml - combinations - combinations - source of calories and essential fatty oils for patients requiring parenteral nutrition

ליפופונדין אם.סי.טיאל.סי.טי % 20 ישראל - עברית - Ministry of Health

ליפופונדין אם.סי.טיאל.סי.טי % 20

lapidot medical import and marketing ltd - soya oil; triglycerides, medium-chain - תחליב לאינפוזיה - soya oil 100 mg/ml; triglycerides, medium-chain 100 mg/ml - combinations - combinations - source of calories and essential fatty oils for patients requiring parenteral nutrition.

נסיבין % 0.025 ישראל - עברית - Ministry of Health

נסיבין % 0.025

naveh pharma ltd - oxymetazoline hydrochloride 0.5 mg/ml - solution - oxymetazoline - for temporary relief of nasal congestion due to cold or sinusitis or allergies of the upper respiratory tract.

נסיבין % 0.05 ישראל - עברית - Ministry of Health

נסיבין % 0.05

naveh pharma ltd - oxymetazoline hydrochloride 0.5 mg/ml - solution - oxymetazoline - relief of nasal congestion, which is a result of common colds, sinusitis, hay fever or allergies of the upper respiratory system.

טרקליר 62.5 מג ישראל - עברית - Ministry of Health

טרקליר 62.5 מג

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 62.5 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

טרקליר 125 מג ישראל - עברית - Ministry of Health

טרקליר 125 מג

j-c health care ltd - bosentan - טבליות מצופות פילם - bosentan 125 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease

סנדאימון   ניאורל   50 מג כמוסות ישראל - עברית - Ministry of Health

סנדאימון ניאורל 50 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.

סנדאימון   ניאורל   100 מג כמוסות ישראל - עברית - Ministry of Health

סנדאימון ניאורל 100 מג כמוסות

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.